Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 21-25 of 25 (Search time: 0.001 seconds).

previous
1
2
3
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2015	HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescents	Skinner, S.R.; Davies, C.; Cooper, S.; Stoney, T.; Marshall, H.; Jones, J.; Collins, J.; Hutton, H.; Parrella, A.; Zimet, G.; Regan, D.G.; Whyte, P.; Brotherton, J.M.L.; Richmond, P.; McCaffrey, K.; Garland, S.M.; Leask, J.; Kang, M.; Braunack-Mayer, A.; Kaldor, J.; et al.
	2017	Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)	McElvaney, N.; Burdon, J.; Holmes, M.; Glanville, A.; Wark, P.; Thompson, P.; Hernandez, P.; Chlumsky, J.; Teschler, H.; Ficker, J.; Seersholm, N.; Altraja, A.; Mäkitaro, R.; Chorostowska-Wynimko, J.; Sanak, M.; Stoicescu, P.; Piitulainen, E.; Vit, O.; Wencker, M.; Tortorici, M.; et al.
	2017	Developing a set of core outcomes for trials in hemodialysis: an international Delphi survey	Evangelidis, N.; Tong, A.; Manns, B.; Hemmelgarn, B.; Wheeler, D.C.; Tugwell, P.; Crowe, S.; Harris, T.; Van Biesen, W.; Winkelmayer, W.C.; Sautenet, B.; O'Donoghue, D.; Tam-Tham, H.; Youssouf, S.; Mandayam, S.; Ju, A.; Hawley, C.; Pollock, C.; Harris, D.C.; Johnson, D.W.; et al.
	2012	Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010	Salomon, J.A.; Vos, T.; Hogan, D.R.; Gagnon, M.; Naghavi, M.; Mokdad, A.; Begum, N.; Shah, R.; Karyana, M.; Kosen, S.; Farje, M.R.; Moncada, G.; Dutta, A.; Sazawal, S.; Dyer, A.; Seiler, J.; Aboyans, V.; Baker, L.; Baxter, A.; Benjamin, E.J.; et al.
	2017	Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis	Herold, T.; Schneider, S.; Metzeler, K.; Neumann, M.; Hartmann, L.; Roberts, K.; Konstandin, N.; Greif, P.; Braeundl, K.; Ksienzyk, B.; Huk, N.; Schneider, I.; Zellmeier, E.; Jurinovic, V.; Mansmann, U.; Hiddemann, W.; Mullighan, C.; Bohlander, S.; Spiekermann, K.; Hoelzer, D.; et al.